About AQEMIA

AQEMIA is a next-gen pharmatech company generating one of the world's fastest-growing drug discovery pipeline.

Our mission is to design fast innovative drug candidates for dozens of critical diseases, such as immuno-oncology.

Our unique approach leverages quantum-inspired physics algorithms to power generative AI in designing novel drug candidates—without relying on experimental data.

We already delivered several drug discovery successes within our internal pipeline and through collaborations with pharmaceutical companies. Our most advanced programs are currently in vivo optimization.

About Aqemia

Aqemia is a pioneering TechBio company leveraging physics-based computational methods and machine learning to scale drug discovery. Our Molecular Simulations Team plays a crucial role in maximising the impact of physics-based computational methods in our drug discovery programs.

Role Overview

We are looking for a Manager to lead our Molecular Simulations team, which plays a key role in advancing our drug discovery programs. The team focuses on applying and optimising physics-based computational methods to support hit discovery and lead optimisation, helping to accelerate the development of novel drug candidates. The ideal candidate combines strong leadership skills to guide a team of scientists with deep expertise in statistical mechanics and computational chemistry.

Key Responsibilities

Qualifications & Experience

Nice to have

Preferred Mindset

- Ability to set a technical vision for the team and align it with company objectives.

- Collaborative Leader: Thrives in an interdisciplinary environment and values teamwork.

- Pragmatic and Impact-Driven: Balances scientific rigor with real-world application.

- Growth-Oriented: Invests in the development of team members and fosters a culture of continuous learning.

- Passionate about pushing the boundaries of physics-based drug discovery.

Why Join Us ?

At AQEMIA, we work for a mission: joining us means having your own impact on changing the way drugs are discovered, and helping to shape the direction of our fast-growing company and team.

Expanding Drug Discovery Pipeline : Focused on critical therapeutic areas like Oncology, CNS, Immuno-inflammation... with in vivo proof of concept/patent stage programs. Collaborations with top Pharma, including a $140M Sanofi deal.

Interdisciplinary Team : brilliant talent from tech and life sciences.

DeepTech Recognition: Part of French Tech 120 and France 2030.

Prime Location : Based in central Paris and London (King's Cross) with the possibility of 2 remote days per week.

International Environment : The work language is English - relocation support and French lessons granted if needed.

Strong Financial Backing : $100M raised from leading European and International investors